Abstract
Reduction of lung inflammation is one of the goals in the treatment of cystic fibrosis (CF). As a result, antiinflammatory therapies are often used to decrease the excessive and persistent inflammatory response. Although effective, the use of systemic corticosteroids has been limited due to unacceptable adverse effects. Inhaled corticosteroids (ICS) are often used empirically to treat children and adults with CF despite the lack of evidence of their benefit. Concern about effects on growth and adrenal suppression have been reduced, but not eliminated with the use of ICS. Herein, mechanisms of action of corticosteroids, the effectiveness and safety of ICS usage in CF are reviewed.
Keywords: Inhaled corticosteroids, cystic fibrosis, adverse effects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Inhaled Corticosteroids In Treatment of Cystic Fibrosis
Volume: 11 Issue: 3
Author(s): Ela Erdem and Refika Ersu
Affiliation:
Keywords: Inhaled corticosteroids, cystic fibrosis, adverse effects
Abstract: Reduction of lung inflammation is one of the goals in the treatment of cystic fibrosis (CF). As a result, antiinflammatory therapies are often used to decrease the excessive and persistent inflammatory response. Although effective, the use of systemic corticosteroids has been limited due to unacceptable adverse effects. Inhaled corticosteroids (ICS) are often used empirically to treat children and adults with CF despite the lack of evidence of their benefit. Concern about effects on growth and adrenal suppression have been reduced, but not eliminated with the use of ICS. Herein, mechanisms of action of corticosteroids, the effectiveness and safety of ICS usage in CF are reviewed.
Export Options
About this article
Cite this article as:
Erdem Ela and Ersu Refika, Inhaled Corticosteroids In Treatment of Cystic Fibrosis, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (3) . https://dx.doi.org/10.2174/1871523011202030206
DOI https://dx.doi.org/10.2174/1871523011202030206 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GAMESS As a Free Quantum-Mechanical Platform for Drug Research
Current Topics in Medicinal Chemistry The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Phytochemicals-based Therapeutics against Alzheimer's Disease: An Update
Current Topics in Medicinal Chemistry Role of Metalloproteinases in Tendon Pathophysiology
Mini-Reviews in Medicinal Chemistry Targeted Drug Delivery for Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Targeting Cytokines for Morphine Tolerance: A Narrative Review
Current Neuropharmacology Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging Dendritic Cells in Hepatitis Virus Infection: A Legatus Within
Current Immunology Reviews (Discontinued) Lipid-based Self-Adjuvanting Vaccines
Current Drug Delivery Vitamins in Heart Failure: Friend or Enemy?
Current Pharmaceutical Design Translational siRNA Therapeutics Using Liposomal Carriers: Prospects & Challenges
Current Gene Therapy Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment
Current Alzheimer Research Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?
Current Vascular Pharmacology Strategies for In Vivo siRNA Delivery in Cancer
Mini-Reviews in Medicinal Chemistry The Determinative Role of Cytokines in Retinopathy of Prematurity
Current Molecular Medicine Advances in the Treatment of Chronic Granulomatous Disease by Gene Therapy
Current Gene Therapy Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
Cardiovascular & Hematological Disorders-Drug Targets Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Proteins: A to Z
Protein & Peptide Letters Relevance of Postprandial Lipemia in Metabolic Syndrome
Current Vascular Pharmacology